An award-winning approach to timely diagnosis of degenerative cervical myelopathy—and why it matters
BY DR MICHAEL G. FEHLINGS
We need to spread the word of DCM
The other critical element in regard to correctly diagnosing more DCM patients is to increase everybody’s knowledge on the subject. In fact, the RECODE-DCM project has named raising awareness of DCM—both among healthcare professionals and among the general public—as its main research priority for the future. We simply need to spread the word, and not just among orthopedic specialists and neurosurgeons. We also urgently need to educate other specialists as well as family physicians and caregivers about the condition itself as well as the best ways of correctly diagnosing it. Our aim must be to reach those medical professionals who will regularly be the first point of contact for undiagnosed DCM patients.
The most important symptoms for heart attacks and strokes are common knowledge nowadays. Many lay people are aware of them and will react appropriately when faced with a patient displaying them. My aim would be for us as a society to reach a point where the same can be said for the most common DCM symptoms. If you hear a family member complaining about numbness in their hands, or if you notice a friend walking less steadily than the last time you saw them, then, in an ideal world, DCM should be among the first things you think about as a possible cause.
Read the awarded paper:
Tetreault L, Kalsi-Ryan S, Benjamin Davies, et al. Degenerative Cervical Myelopathy: A Practical Approach to Diagnosis. Global Spine Journal. 2022;12(8):1881-1893. doi:10.1177/21925682211072847
About the author:
Professor Michael G Fehlings, PhD, MD, FACS, FRCSC, is a Professor of Neurosurgery at the University of Toronto. He is the Vice Chair Research in the Department of Surgery, Co-Director of the University of Toronto Spine Program, holds the Robert Campeau Foundation / Dr. C.H. Tator Chair in Brain and Spinal Cord Research at the University Health Network, is a Scientist at the McEwen Centre for Regenerative Medicine, and a Senior Scientist at the Krembil Brain Institute. His main clinical interests are in spinal neurosurgery, and his research focus is on molecular mechanisms underlying spinal cord injury. Michael Fehlings is a Steering Committee member of the AO Spine Knowledge Forum Spinal Cord Injury and Chairperson of the AO ITC Clinical Science Advisory Commission.
You might also be interested in:
AO Spine KF symposia at the GSC
AO Spine Knowledge Forums moderate several symposia and share their latest knowledge at the GSC.
New research toolkit will improve research on DCM
The AO Spine Knowledge Forum Spinal Cord Injury has created a toolkit to help scientists and make DCM studies robust, comparable, and focused on the most relevant open questions.
AO Spine RECODE-DCM
Watch the latest videos and find all the details of the study and its outcomes.
AO Spine Knowledge Forum Spinal Cord Injury
Building on worldwide research partnerships for global impact.
Disclaimer
The articles included in the AO Spine Blog represent the opinion of individual authors exclusively and not necessarily the opinion of AO Spine or AO Foundation.


